About a third of Americans take a multivitamin with minerals — the most commonly used type of dietary supplement in the US. A new study looked at the impact of this use on breast cancer survival.

Two leading professional medical societies have joined forces to issue a new recommendation for all newly diagnosed invasive breast cancer patients. The aim of these guidelines is to improve precision treatment of an aggressive form of the disease.

Learning you have breast cancer can be shocking and life-changing. Some women don’t ever want to go through the experience again and choose to have both of their breasts removed to protect themselves, even if the cancer is limited to only one breast. A new study looked at the survival benefits of such a decision.

Women whose breast cancer has spread to the lymph nodes often have chemotherapy. This can be done before surgery to give her the possibility of having breast-conserving therapy. But how do physicians know if there’s still cancer in the lymph nodes after the chemotherapy?

Research has demonstrated that physical activity lowers the risk of breast cancer. What hasn’t been clear are the specifics – how long and how intense the exercise needs to be to cut risks. A new study drills down on how exercise can reduce a postmenopausal woman's chances of developing breast cancer.

Researchers and scientists continue to find new and better ways of treating breast cancer. And may of these improvements not only help patients live longer, but are gentler on the patient and improve quality of life during treatment.

One of the first places breast cancer spreads is to the lymph nodes closest to the tumor. Learning where the cancer has spread is important for making treatment decisions. A new review looked at the risks and benefits of various surgical means of removing lymph nodes.

Every other year, the American Cancer Society publishes statistics and trends about breast cancer. Breast Cancer Facts & Figures 2013-2014 offers some interesting insights into the current state of the disease.

For the first time in its history, the US Food and Drug Administration has approved a medication for the pre-surgical (neoadjuvant) treatment of early-stage (I, II) breast cancer.

HER2 is a protein that can be overexpressed in breast cancer, causing an aggressive disease. While there are treatments that target HER2, this form of cancer is tenacious. Scientists have found a new treatment option for this type of breast cancer.